CRDL Q4 2025 Earnings Narrower Than Expected Loss as Cardiol Therapeutics Advances Clinical Pipeline PHGE Q4 2025 Earnings Severe EPS Miss as BiomX Continues Clinical Development MarineMax Inc Q1 2026 Earnings EPS Miss Mirrors Challenging Boating Environment TEVA Q1 2026 Earnings EPS Beats Estimates by Nearly 9 Stock Inches Higher APWC Q3 1997 Earnings EPS Misses Estimates Amid Cost Pressures Nathans Famous Inc NATH Q4 2024 Earnings EPS of 096 Reported as Stock Moves Lower